Russell Investments Group’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-95,822
Closed -$178K 3220
2023
Q3
$178K Buy
95,822
+17,689
+23% +$32.9K ﹤0.01% 2512
2023
Q2
$215K Buy
78,133
+19,099
+32% +$52.5K ﹤0.01% 2459
2023
Q1
$185K Buy
59,034
+13,798
+31% +$43.3K ﹤0.01% 2491
2022
Q4
$267K Buy
45,236
+7,243
+19% +$42.7K ﹤0.01% 2494
2022
Q3
$332K Sell
37,993
-648
-2% -$5.66K ﹤0.01% 2393
2022
Q2
$290K Buy
+38,641
New +$290K ﹤0.01% 2448
2021
Q4
Sell
-5,056
Closed -$225K 3002
2021
Q3
$225K Buy
5,056
+4,494
+800% +$200K ﹤0.01% 2742
2021
Q2
$21K Buy
+562
New +$21K ﹤0.01% 3175